tiprankstipranks
Trending News
More News >
Krystal Biotech, Inc. (KRYS)
:KRYS
US Market

Krystal Biotech (KRYS) Income Statement

Compare
602 Followers

Krystal Biotech Income Statement

Last quarter (Q3 2025), Krystal Biotech's total revenue was $97.80M, an increase of 16.65% from the same quarter last year. In Q3, Krystal Biotech's net income was $79.36M. See Krystal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 290.51M$ 50.70M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 270.45M$ 47.60M$ 0.00$ 0.00$ -1.85M
Operating Expenses
$ 204.76M$ 157.33M$ 145.20M$ 68.28M$ 31.15M
Depreciation and Amortization
$ 6.71M$ 5.91M$ 3.38M$ 1.85M$ 1.85M
EBITDA
$ 109.91M$ -91.32M$ -116.81M$ -66.23M$ -30.32M
Operating Income
$ 65.69M$ -109.73M$ -145.20M$ -68.28M$ -33.00M
Other Income/Expenses
$ 29.66M$ 122.62M$ 5.22M$ -1.29M$ 832.00K
Pretax Income
$ 95.36M$ 12.90M$ -139.97M$ -69.57M$ -32.17M
Net Income
$ 89.16M$ 10.93M$ -139.97M$ -69.57M$ -32.17M
Per Share Metrics
Basic EPS
$ 3.12$ 0.40$ -5.49$ -3.13$ -1.71
Diluted EPS
$ 3.00$ 0.39$ -5.49$ -3.13$ -1.71
Weighted Average Shares Outstanding
28.59M 27.15M 25.49M 22.20M 18.79M
Weighted Average Shares Outstanding (Diluted)
29.74M 27.75M 25.49M 22.20M 18.79M
Currency in USD

Krystal Biotech Earnings and Revenue History